Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Pu...
Leadership
Christopher J. Schaber Ph.D.
Chairman of the Board of Directors, CEO & President
Jonathan L. Guarino CPA, CGMA
Senior VP, CFO & Corporate Secretary
Oreola Donini Ph.D.
Senior VP & Chief Scientific Officer
Richard C. Straube M.D., MSc.
Consulting Chief Medical Officer
Adam T. Rumage
Senior VP of Project Management & Regulatory Affairs
